Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.
Mayfield
mayfield.com ↗Activity from announced rounds
Mayfield is an early-stage technology investor focused on being the first institutional backer of AI founders, with most of its investments beginning at company inception.
Its AI investing reaches into the physical infrastructure needed for adoption as well as software. The firm’s Lumilens investment addresses optical connectivity between processors and computing systems, illustrating its interest in technical bottlenecks below the application layer.
Mayfield’s CXO of the Future community connects it with enterprise leaders. That commercial perspective complements its inception-stage work when founders need to understand the requirements of corporate buyers for a new technology.
Sources
- Rounds participated in
- 8
- Confirmed lead rounds
- 0 7 roles undisclosed
- New companies
- 7 First participation on record · 1 follow-on
- Funding in participating rounds
- $1.3B 8 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
8 in this selectionDevelops ultra-low-power silicon for AI data centers and Physical AI systems
Builds environments and infrastructure for reliable AI agents
Provides open-standard AI networking infrastructure for ultra-low-latency training and inference
Builds silicon photonics chips and PDK tools for AI, telecom, and quantum computing markets
Develops Artificial Chip Intelligence (ACI) for semiconductor design
Builds robotic intelligence for real-world environments using video-predictive control
Provides open-standard AI networking infrastructure for ultra-low-latency training and inference